Secondary erythrocytosis in cyanotic congenital heart disease (CCHD) is a compensatory response to chronic hypoxia which

should be managed with caution. CCHD patients, who have compensated erythrocytosis but do not manifest significant neurologic

symptoms,may experience secondary life-threatening complications such as stroke in case of inappropriate phlebotomy. This study

reports a young man with CCHD who developed frequently repeated transient neurologic deficits with various presentations after

one session of phlebotomy.The symptoms resolved a few days after the hematocrit (Hct) level returned to the prephlebotomy leve

Assadi, Majid

Mehdizadeh, Somayeh

Nemati, Reza

Pourbehi, Gholam Reza

Pourbehi, Mohamad Reza

Salimipour, Hooman

Case Reports in Neurological Medicine

PubMed

Secondary erythrocytosis in cyanotic congenital heart disease (CCHD) is a compensatory response to chronic hypoxia which should be managed with caution. CCHD patients, who have compensated erythrocytosis but do not manifest significant neurologic symptoms, may experience secondary life-threatening complications such as stroke in case of inappropriate phlebotomy. This study reports a young man with CCHD who developed frequently repeated transient neurologic deficits with various presentations after one session of phlebotomy. The symptoms resolved a few days after the hematocrit (Hct) level returned to the prephlebotomy level.</jats:p

Hooman Salimipour

Somayeh Mehdizadeh

Reza Nemati

Mohamad Reza Pourbehi

Gholam Reza Pourbehi

Majid Assadi

Crossref

Case ReportUnusual Neurologic Manifestations of a Patient withCyanotic Congenital Heart Disease after PhlebotomyHooman Salimipour,1 Somayeh Mehdizadeh,1 Reza Nemati,1,2 Mohamad Reza Pourbehi,3Gholam Reza Pourbehi,1 and Majid Assadi41Department of Neurology, Bushehr University of Medical Sciences, Bushehr 7514633341, Iran2The Persian Gulf Tropical Medicine Research Center, Bushehr University of Medical Sciences, Bushehr 7514763448, Iran3Department of Cardiology, Bushehr University of Medical Sciences, Bushehr 7514633341, Iran4The Persian Gulf Nuclear Medicine Research Center, Bushehr University of Medical Sciences, Bushehr 7514633341, IranCorrespondence should be addressed to Reza Nemati; rznemati@yahoo.comReceived 14 December 2014; Accepted 26 March 2015Academic Editor: Tapas Kumar BanerjeeCopyright © 2015 Hooman Salimipour et al. This is an open access article distributed under the Creative Commons AttributionLicense, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properlycited.Secondary erythrocytosis in cyanotic congenital heart disease (CCHD) is a compensatory response to chronic hypoxia whichshould bemanaged with caution. CCHDpatients, who have compensated erythrocytosis but do notmanifest significant neurologicsymptoms, may experience secondary life-threatening complications such as stroke in case of inappropriate phlebotomy.This studyreports a young man with CCHD who developed frequently repeated transient neurologic deficits with various presentations afterone session of phlebotomy.The symptoms resolved a few days after the hematocrit (Hct) level returned to the prephlebotomy level.1. IntroductionSecondary erythrocytosis is a physiological response to tissuehypoxia inwhich there are an increased number of circulatingred blood cells, an improved oxygen carrying capacity, and anenhanced blood viscosity.This adaptation results in sufficienttissue oxygenation at a higher blood viscosity and Hct; how-ever this equilibrium may be impaired if excessive erythro-cytosis impairs oxygen delivery by increasing blood viscosityand eventually inverses the beneficial effects of erythrocytosis[1]. Cerebrovascular event has been previously consideredas one of the most serious complications of secondaryerythrocytosis in CCHD, although a large study in adultpatients with CCHD showed no increased risk of stroke [2].Patients with secondary erythrocytosis related to CCHDcan be divided into two groups as follows: first group withstable “compensated” erythrocytosis, adequate iron stores,and absent or mild hyperviscosity symptoms and secondgroup with “decompensated” erythrocytosis, iron deficiencystates, and recurrent hyperviscosity symptoms [3].For patients with compensated secondary erythrocytosis,phlebotomy did not indicate any usefulness when theyexhibit mild,moderate, or no neurologic symptoms related tocerebral hyperviscosity. Repeated phlebotomy was associatedwith iron stores depletion, microcytosis, blood hyperviscos-ity, and impaired oxygen delivery [4].In this paper, we report a 35-year-old man with com-plex CCHD, who showed unusual presentation of recurrentvarious transient neurologic deficits after first therapeuticphlebotomy.2. CaseA 35-year-old man is presented here as a known case ofcomplex CCHD including dextrocardia, ventricular septaldefect, transposition of the great arteries, atrial septal defect,pulmonary stenosis, with a history of previous admission forcardiac evaluation, and catheterization for diagnosis of heartanatomy and RV pressure 25 years ago. However, the patienthas not shown any symptoms and no surgical interventionHindawi Publishing CorporationCase Reports in Neurological MedicineVolume 2015, Article ID 924862, 3 pageshttp://dx.doi.org/10.1155/2015/9248622 Case Reports in Neurological Medicinehas been done on the patient. He had been feeling well until2 days before admission when he reported some neurologicalsymptoms like dizziness, tingling, and fatigue. He was visitedby an internist who advised him to undergo a phlebotomy,250 cc with normal saline replacement, for three continuousdays due to his high Hct level (Hct: 64.5). After the first ses-sion, Hct and hemoglobulin (Hb) oxygen saturation were 58and 76%, respectively. At the second session of phlebotomy,immediately after several unsuccessful painful intravenousangiocut catheter insertions, the patient developed tongueand right body tingling and paresthesia, later progressed todysarthria and stiffness and tightness in right extremitieswhich were resolved in about 20 seconds. During recovery,the same symptoms occurred in the left upper limb whichwere all resolved completely in about 30 seconds. Emergencybrain CT has not showed cerebral hemorrhage or infarctionand brain magnetic resonance imaging (MRI) and diffu-sion weighted MR has not revealed any more information.Transthoracic echocardiography did not also show obviousthrombus. The patient was admitted in stroke unit andhydration, medication with aspirin 80mg, and infusion ofheparin with rate of 1000 unit per hour started. Although thepatient was on antiplatelet and anticoagulant, his symptomsfrequently recurred in various forms alternating in both sides:right and left hemiparesis, stiffness, loss of dexterity, choreaand dystonic movement, facial and tongue tingling, andparesthesia. During symptomatic period, neurologic exam-ination revealed transient Babinski signs at several times.The patient’s complaints continued for several days and sinceday 4 after presentation, frequency and severity of symptomsdecreased. Brain and neck MR angiography, cervical MRI,Transcranial Doppler (TCD) sonography and monitoring,and electroencphalography were normal. Other blood countparameters (white blood cell: 7000 cells/mcL, mean corpus-cular volume: 84 fL, and platelet count: 155000 cells/mcL),serum iron (88𝜇g/dL), ferritin (110 ng/mL), and homocys-teine (13 𝜇mol/L) were in normal range. After discharge ofthe patient from hospital, frequency and severity of theneurologic attacks gradually decreased coinciding with anincrease in Hb and Hct. Terminally, his complaint resolvedat an Hct level (62.7%) and an Hb O2saturation (85%) nearto the amount before admission. Onemonth later, the patientonly occasionally complained from a limb tingling similar tothe symptom before phlebotomy.3. DiscussionOur patient manifested repeated transient neurologic deficitsafter the first session of phlebotomy and his symptoms werecompatible with the involvement of various cerebral areas,probably originating from an ischemic process.Polycythemic cyanotic patients experience two differentsymptoms of hyperviscosity symptoms and thrombotic event[1]. The former symptom, hyperviscosity, can sometimes bemisinterpreted as thrombotic event and lead to inappropriatephlebotomies [3]. Hyperviscosity is generally associated withimpaired tissue perfusion and tissue oxygen delivery whichcauses symptoms such as headache, visual disturbance, loss ofconcentration, paresthesia, muscle weakness, and fatigue [3].The more serious presentation of polycythemia is throm-botic event inclusive of cerebrovascular accident (CVA) andtransient ischemic attacks (TIA)which are usuallymanifested[3] as symptoms or signs of hemiparesis and/or hemisensorydefects, cortical blindness, aphasia, dysarthria, dysphagiaataxia, or drop attacks, distinguishing thrombotic event fromhyperviscosity [5].Our patient had both types of symptoms: firstly hepresented limb tingling and dizziness that was related tohyperviscosity, but after a single therapeutic phlebotomy, hedeveloped unusual various transient symptoms that seemedto have resulted from ischemia. Several mechanisms mightbe involved in cerebral ischemia in patients with CCHDlike hyperviscosity, iron deficiency anemia, thrombosis, orassociated vascular risk factor [2, 3].Despite a correlation between Hct level and vascularocclusive in polycythemia vera (PV), the association betweenhyperviscosity and vascular thrombosis is not yet reportedin adult patients with CCHD and secondary erythrocytosis[3]. Although PV is associated with vascular accident suchas stroke [5], Perloff et al. did not report an increasedincidence of cerebral infarction in adult patients who sufferfrom CCHD and secondary erythrocytosis [4]. Ammash andWarnes reported an increased risk of CVAs in adult patientswith CCHD which related to hypertension, atrial fibrillation,repeated phlebotomies, and iron deficiency, but they havenot mentioned any correlation between Hg or Hct level andstroke [2].Therapeutic guidelines in PV recommend maintainingHct level lower than 45 through phlebotomy. However, it isnot proved that phlebotomy is associated with a lower risk ofthrombosis, because iron deficiency resulting from frequentphlebotomy may even cause a higher incidence of vascularocclusion [1].Patients with CCHD who do not have hyperviscositysymptoms are not advised to have phlebotomy unless patientis symptomatic atHct level above 65 and is not dehydrated [1].Dehydration and iron deficiencymay precipitate or aggravatesymptomatic hyperviscosity and thrombotic event and haveto be managed before phlebotomy in patients with CCHDwith Hct level of >65% [3].If venesection is performed without volume replacementin patient suffering from dehydration, the consequences ofthe acute fall in systemic blood flow and oxygen deliverycan impair cardiovascular and cerebral perfusion [1]. Irondeficiency anemia is associated with microcytic erythrocytesthat are rigid and difficult to pass through microcirculation,ultimately increasing the risk of hyperviscosity symptomsand CVAs in patients with secondary erythrocytosis [3].Our patient did not have iron deficiency because onesession of phlebotomy is not enough for iron depletion tooccur and serum iron and ferritinwere also in a normal range.Suspicious of probable dehydration, the patient was treatedwith sufficient intravenous solution, which did not resolve thepatient’s symptoms.Dinia et al. reported a 29-year-old woman with a cor-rected CCHD suffering from advancing pulmonary hyper-tension and secondary erythrocytosis (Hct: 63%). After twosessions of therapeutic phlebotomy, the patient experiencedCase Reports in Neurological Medicine 3three instances of TIA that disappeared immediately after theinfusion of heparin.The Hct value after first phlebotomy was57.5%. Bilateral TCD monitoring showed several microem-bolic signals (MES) on middle cerebral arteries of both sideswhich disappeared after anticoagulant therapy. The authorsbelieve that the clinical events may be due to hyperviscosityand microembolization of aggregated red blood cells [6].However, in our patient, treatment with heparin infusiondid not resolve neurologic episodes which were frequentlyrepeated every few minutes. TCD sonography and monitor-ing have not shown any significant arterial stenosis andMES,respectively. MES considered silent cerebral emboli that areusually detected during TCD monitoring of the intracranialarteries [7]. There seems to be another mechanism involvedin pathogenesis of neurologic episodes in our case.Despite improvement of tissue oxygen delivery and cere-bral blood flow following phlebotomy, blood oxygen carryingcapacity decreases in secondary erythrocytosis [8].Our case had an Hct level about 64.5% and an Hb O2saturation around 85%, which decreased after phlebotomyto 58% and 76%, respectively. His neurologic deficit attacksappeared after a decrease in Hct levels andHb oxygen satura-tion. Gradually, there was a cut in the frequency of theseattacks and their eventual disappearance coincided with anincrease in Hb O2saturation and Hct level to the prephle-botomy status. It is possible that phlebotomy has causeda reduced arterial oxygen saturation and finally might bemanifested as neurologic deficits.In conclusion, our case manifested unusual neurologicdeficits after one session of inappropriate phlebotomy. Thedeficits resolved only after Hct level reached the prephle-botomy level. It is important to note that lack of knowl-edge about the abovementioned unusual presentations as aresult of injudicious phlebotomy and accompanying probablemechanisms may result in inappropriate and occasionallylife-threatening treatments such as anticoagulation therapy.Conflict of InterestsThe authors declare that they have no conflict of interests.References[1] S. A. Thorne, “Management of polycythaemia in adults withcyanotic congenital heart disease,”Heart, vol. 79, no. 4, pp. 315–316, 1998.[2] N. Ammash andC. A.Warnes, “Cerebrovascular events in adultpatients with cyanotic congenital heart disease,” Journal of theAmerican College of Cardiology, vol. 28, no. 3, pp. 768–772, 1996.[3] S. S. Rose, A. A. Shah, D. R. Hoover, and P. Saidi, “Cyanotic con-genital heart disease (CCHD) with symptomatic erythrocyto-sis,” Journal of General Internal Medicine, vol. 22, no. 12, pp.1775–1777, 2007.[4] J. K. Perloff, A. J. Marelli, and P. D. Miner, “Risk of stroke inadults with cyanotic congenital heart disease,” Circulation, vol.87, no. 6, pp. 1954–1959, 1993.[5] S. Costa, J. Marques, A. Barradas, and A. Valverde, “Transientspinal cord ischemia as presenting manifestation of polycythe-mia vera,” Case Reports in Neurology, vol. 3, no. 3, pp. 284–288,2011.[6] L. Dinia, D. Rizzi, C. Gandolfo, and M. del Sette, “Disappear-ance of microembolic signals after heparin in acute cerebralischemia due to cyanotic heart disease with polyglobulia,”Cerebrovascular Diseases, vol. 21, no. 4, pp. 294–295, 2006.[7] A. Shariat, E. Yaghoubi, R. Nemati, A. R. Moaref, K. Aghasa-deghi, and A. B. Haghighi, “Microembolic signals in patientswith cryptogenic stroke with or without patent foramen ovale,”Journal of Stroke and Cerebrovascular Diseases, vol. 21, no. 8, pp.662–666, 2012.[8] A. P. DeFilippis, K. Law, S. Curtin, and J. R. Eckman, “Blood isthicker than water: the management of hyperviscosity in adultswith cyanotic heart disease,” Cardiology in Review, vol. 15, no. 1,pp. 31–34, 2007.Submit your manuscripts athttp://www.hindawi.comStem CellsInternationalHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014MEDIATORSINFLAMMATIONofHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Behavioural NeurologyEndocrinologyInternational Journal ofHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Disease MarkersHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014BioMed Research InternationalOncologyJournal ofHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Oxidative Medicine and Cellular LongevityHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014PPAR ResearchThe Scientific World JournalHindawi Publishing Corporation http://www.hindawi.com Volume 2014Immunology ResearchHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Journal ofObesityJournal ofHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014 Computational and  Mathematical Methods in MedicineOphthalmologyJournal ofHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Diabetes ResearchJournal ofHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Research and TreatmentAIDSHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Gastroenterology Research and PracticeHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Parkinson’s DiseaseEvidence-Based Complementary and Alternative MedicineVolume 2014Hindawi Publishing Corporationhttp://www.hindawi.com

Unusual Neurologic Manifestations of a Patient with Cyanotic Congenital Heart Disease after Phlebotomy

Secondary erythrocytosis in cyanotic congenital heart disease (CCHD) is a compensatory response to chronic hypoxia which

should be managed with caution. CCHD patients, who have compensated erythrocytosis but do not manifest significant neurologic

symptoms,may experience secondary life-threatening complications such as stroke in case of inappropriate phlebotomy. This study

reports a young man with CCHD who developed frequently repeated transient neurologic deficits with various presentations after

one session of phlebotomy.The symptoms resolved a few days after the hematocrit (Hct) level returned to the prephlebotomy level

Salimipour,, Hooman

Pourbehi,, Mohamad Reza

Bushehr University of Medical Sciences Repository

Unusual Neurologic Manifestations of a Patient with

Cyanotic Congenital Heart Disease after Phlebotomy

Pourbehi, Gholamreza

Pourbehi, Mohammad Reza

Case ReportUnusual Neurologic Manifestations of a Patient withCyanotic Congenital Heart Disease after PhlebotomyHooman Salimipour,1 Somayeh Mehdizadeh,1 Reza Nemati,1,2 Mohamad Reza Pourbehi,3Gholam Reza Pourbehi,1 and Majid Assadi41Department of Neurology, Bushehr University of Medical Sciences, Bushehr 7514633341, Iran2The Persian Gulf Tropical Medicine Research Center, Bushehr University of Medical Sciences, Bushehr 7514763448, Iran3Department of Cardiology, Bushehr University of Medical Sciences, Bushehr 7514633341, Iran4The Persian Gulf Nuclear Medicine Research Center, Bushehr University of Medical Sciences, Bushehr 7514633341, IranCorrespondence should be addressed to Reza Nemati; rznemati@yahoo.comReceived 14 December 2014; Accepted 26 March 2015Academic Editor: Tapas Kumar BanerjeeCopyright © 2015 Hooman Salimipour et al. This is an open access article distributed under the Creative Commons AttributionLicense, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properlycited.Secondary erythrocytosis in cyanotic congenital heart disease (CCHD) is a compensatory response to chronic hypoxia whichshould bemanaged with caution. CCHDpatients, who have compensated erythrocytosis but do notmanifest significant neurologicsymptoms, may experience secondary life-threatening complications such as stroke in case of inappropriate phlebotomy.This studyreports a young man with CCHD who developed frequently repeated transient neurologic deficits with various presentations afterone session of phlebotomy.The symptoms resolved a few days after the hematocrit (Hct) level returned to the prephlebotomy level.1. IntroductionSecondary erythrocytosis is a physiological response to tissuehypoxia inwhich there are an increased number of circulatingred blood cells, an improved oxygen carrying capacity, and anenhanced blood viscosity.This adaptation results in sufficienttissue oxygenation at a higher blood viscosity and Hct; how-ever this equilibrium may be impaired if excessive erythro-cytosis impairs oxygen delivery by increasing blood viscosityand eventually inverses the beneficial effects of erythrocytosis[1]. Cerebrovascular event has been previously consideredas one of the most serious complications of secondaryerythrocytosis in CCHD, although a large study in adultpatients with CCHD showed no increased risk of stroke [2].Patients with secondary erythrocytosis related to CCHDcan be divided into two groups as follows: first group withstable “compensated” erythrocytosis, adequate iron stores,and absent or mild hyperviscosity symptoms and secondgroup with “decompensated” erythrocytosis, iron deficiencystates, and recurrent hyperviscosity symptoms [3].For patients with compensated secondary erythrocytosis,phlebotomy did not indicate any usefulness when theyexhibit mild,moderate, or no neurologic symptoms related tocerebral hyperviscosity. Repeated phlebotomy was associatedwith iron stores depletion, microcytosis, blood hyperviscos-ity, and impaired oxygen delivery [4].In this paper, we report a 35-year-old man with com-plex CCHD, who showed unusual presentation of recurrentvarious transient neurologic deficits after first therapeuticphlebotomy.2. CaseA 35-year-old man is presented here as a known case ofcomplex CCHD including dextrocardia, ventricular septaldefect, transposition of the great arteries, atrial septal defect,pulmonary stenosis, with a history of previous admission forcardiac evaluation, and catheterization for diagnosis of heartanatomy and RV pressure 25 years ago. However, the patienthas not shown any symptoms and no surgical interventionHindawi Publishing CorporationCase Reports in Neurological MedicineVolume 2015, Article ID 924862, 3 pageshttp://dx.doi.org/10.1155/2015/9248622 Case Reports in Neurological Medicinehas been done on the patient. He had been feeling well until2 days before admission when he reported some neurologicalsymptoms like dizziness, tingling, and fatigue. He was visitedby an internist who advised him to undergo a phlebotomy,250 cc with normal saline replacement, for three continuousdays due to his high Hct level (Hct: 64.5). After the first ses-sion, Hct and hemoglobulin (Hb) oxygen saturation were 58and 76%, respectively. At the second session of phlebotomy,immediately after several unsuccessful painful intravenousangiocut catheter insertions, the patient developed tongueand right body tingling and paresthesia, later progressed todysarthria and stiffness and tightness in right extremitieswhich were resolved in about 20 seconds. During recovery,the same symptoms occurred in the left upper limb whichwere all resolved completely in about 30 seconds. Emergencybrain CT has not showed cerebral hemorrhage or infarctionand brain magnetic resonance imaging (MRI) and diffu-sion weighted MR has not revealed any more information.Transthoracic echocardiography did not also show obviousthrombus. The patient was admitted in stroke unit andhydration, medication with aspirin 80mg, and infusion ofheparin with rate of 1000 unit per hour started. Although thepatient was on antiplatelet and anticoagulant, his symptomsfrequently recurred in various forms alternating in both sides:right and left hemiparesis, stiffness, loss of dexterity, choreaand dystonic movement, facial and tongue tingling, andparesthesia. During symptomatic period, neurologic exam-ination revealed transient Babinski signs at several times.The patient’s complaints continued for several days and sinceday 4 after presentation, frequency and severity of symptomsdecreased. Brain and neck MR angiography, cervical MRI,Transcranial Doppler (TCD) sonography and monitoring,and electroencphalography were normal. Other blood countparameters (white blood cell: 7000 cells/mcL, mean corpus-cular volume: 84 fL, and platelet count: 155000 cells/mcL),serum iron (88𝜇g/dL), ferritin (110 ng/mL), and homocys-teine (13 𝜇mol/L) were in normal range. After discharge ofthe patient from hospital, frequency and severity of theneurologic attacks gradually decreased coinciding with anincrease in Hb and Hct. Terminally, his complaint resolvedat an Hct level (62.7%) and an Hb O2saturation (85%) nearto the amount before admission. Onemonth later, the patientonly occasionally complained from a limb tingling similar tothe symptom before phlebotomy.3. DiscussionOur patient manifested repeated transient neurologic deficitsafter the first session of phlebotomy and his symptoms werecompatible with the involvement of various cerebral areas,probably originating from an ischemic process.Polycythemic cyanotic patients experience two differentsymptoms of hyperviscosity symptoms and thrombotic event[1]. The former symptom, hyperviscosity, can sometimes bemisinterpreted as thrombotic event and lead to inappropriatephlebotomies [3]. Hyperviscosity is generally associated withimpaired tissue perfusion and tissue oxygen delivery whichcauses symptoms such as headache, visual disturbance, loss ofconcentration, paresthesia, muscle weakness, and fatigue [3].The more serious presentation of polycythemia is throm-botic event inclusive of cerebrovascular accident (CVA) andtransient ischemic attacks (TIA)which are usuallymanifested[3] as symptoms or signs of hemiparesis and/or hemisensorydefects, cortical blindness, aphasia, dysarthria, dysphagiaataxia, or drop attacks, distinguishing thrombotic event fromhyperviscosity [5].Our patient had both types of symptoms: firstly hepresented limb tingling and dizziness that was related tohyperviscosity, but after a single therapeutic phlebotomy, hedeveloped unusual various transient symptoms that seemedto have resulted from ischemia. Several mechanisms mightbe involved in cerebral ischemia in patients with CCHDlike hyperviscosity, iron deficiency anemia, thrombosis, orassociated vascular risk factor [2, 3].Despite a correlation between Hct level and vascularocclusive in polycythemia vera (PV), the association betweenhyperviscosity and vascular thrombosis is not yet reportedin adult patients with CCHD and secondary erythrocytosis[3]. Although PV is associated with vascular accident suchas stroke [5], Perloff et al. did not report an increasedincidence of cerebral infarction in adult patients who sufferfrom CCHD and secondary erythrocytosis [4]. Ammash andWarnes reported an increased risk of CVAs in adult patientswith CCHD which related to hypertension, atrial fibrillation,repeated phlebotomies, and iron deficiency, but they havenot mentioned any correlation between Hg or Hct level andstroke [2].Therapeutic guidelines in PV recommend maintainingHct level lower than 45 through phlebotomy. However, it isnot proved that phlebotomy is associated with a lower risk ofthrombosis, because iron deficiency resulting from frequentphlebotomy may even cause a higher incidence of vascularocclusion [1].Patients with CCHD who do not have hyperviscositysymptoms are not advised to have phlebotomy unless patientis symptomatic atHct level above 65 and is not dehydrated [1].Dehydration and iron deficiencymay precipitate or aggravatesymptomatic hyperviscosity and thrombotic event and haveto be managed before phlebotomy in patients with CCHDwith Hct level of >65% [3].If venesection is performed without volume replacementin patient suffering from dehydration, the consequences ofthe acute fall in systemic blood flow and oxygen deliverycan impair cardiovascular and cerebral perfusion [1]. Irondeficiency anemia is associated with microcytic erythrocytesthat are rigid and difficult to pass through microcirculation,ultimately increasing the risk of hyperviscosity symptomsand CVAs in patients with secondary erythrocytosis [3].Our patient did not have iron deficiency because onesession of phlebotomy is not enough for iron depletion tooccur and serum iron and ferritinwere also in a normal range.Suspicious of probable dehydration, the patient was treatedwith sufficient intravenous solution, which did not resolve thepatient’s symptoms.Dinia et al. reported a 29-year-old woman with a cor-rected CCHD suffering from advancing pulmonary hyper-tension and secondary erythrocytosis (Hct: 63%). After twosessions of therapeutic phlebotomy, the patient experiencedCase Reports in Neurological Medicine 3three instances of TIA that disappeared immediately after theinfusion of heparin.The Hct value after first phlebotomy was57.5%. Bilateral TCD monitoring showed several microem-bolic signals (MES) on middle cerebral arteries of both sideswhich disappeared after anticoagulant therapy. The authorsbelieve that the clinical events may be due to hyperviscosityand microembolization of aggregated red blood cells [6].However, in our patient, treatment with heparin infusiondid not resolve neurologic episodes which were frequentlyrepeated every few minutes. TCD sonography and monitor-ing have not shown any significant arterial stenosis andMES,respectively. MES considered silent cerebral emboli that areusually detected during TCD monitoring of the intracranialarteries [7]. There seems to be another mechanism involvedin pathogenesis of neurologic episodes in our case.Despite improvement of tissue oxygen delivery and cere-bral blood flow following phlebotomy, blood oxygen carryingcapacity decreases in secondary erythrocytosis [8].Our case had an Hct level about 64.5% and an Hb O2saturation around 85%, which decreased after phlebotomyto 58% and 76%, respectively. His neurologic deficit attacksappeared after a decrease in Hct levels andHb oxygen satura-tion. Gradually, there was a cut in the frequency of theseattacks and their eventual disappearance coincided with anincrease in Hb O2saturation and Hct level to the prephle-botomy status. It is possible that phlebotomy has causeda reduced arterial oxygen saturation and finally might bemanifested as neurologic deficits.In conclusion, our case manifested unusual neurologicdeficits after one session of inappropriate phlebotomy. Thedeficits resolved only after Hct level reached the prephle-botomy level. It is important to note that lack of knowl-edge about the abovementioned unusual presentations as aresult of injudicious phlebotomy and accompanying probablemechanisms may result in inappropriate and occasionallylife-threatening treatments such as anticoagulation therapy.Conflict of InterestsThe authors declare that they have no conflict of interests.References[1] S. A. Thorne, “Management of polycythaemia in adults withcyanotic congenital heart disease,”Heart, vol. 79, no. 4, pp. 315–316, 1998.[2] N. Ammash andC. A.Warnes, “Cerebrovascular events in adultpatients with cyanotic congenital heart disease,” Journal of theAmerican College of Cardiology, vol. 28, no. 3, pp. 768–772, 1996.[3] S. S. Rose, A. A. Shah, D. R. Hoover, and P. Saidi, “Cyanotic con-genital heart disease (CCHD) with symptomatic erythrocyto-sis,” Journal of General Internal Medicine, vol. 22, no. 12, pp.1775–1777, 2007.[4] J. K. Perloff, A. J. Marelli, and P. D. Miner, “Risk of stroke inadults with cyanotic congenital heart disease,” Circulation, vol.87, no. 6, pp. 1954–1959, 1993.[5] S. Costa, J. Marques, A. Barradas, and A. Valverde, “Transientspinal cord ischemia as presenting manifestation of polycythe-mia vera,” Case Reports in Neurology, vol. 3, no. 3, pp. 284–288,2011.[6] L. Dinia, D. Rizzi, C. Gandolfo, and M. del Sette, “Disappear-ance of microembolic signals after heparin in acute cerebralischemia due to cyanotic heart disease with polyglobulia,”Cerebrovascular Diseases, vol. 21, no. 4, pp. 294–295, 2006.[7] A. Shariat, E. Yaghoubi, R. Nemati, A. R. Moaref, K. Aghasa-deghi, and A. B. Haghighi, “Microembolic signals in patientswith cryptogenic stroke with or without patent foramen ovale,”Journal of Stroke and Cerebrovascular Diseases, vol. 21, no. 8, pp.662–666, 2012.[8] A. P. DeFilippis, K. Law, S. Curtin, and J. R. Eckman, “Blood isthicker than water: the management of hyperviscosity in adultswith cyanotic heart disease,” Cardiology in Review, vol. 15, no. 1,pp. 31–34, 2007.

Assadi4, Majid

Secondary erythrocytosis in cyanotic congenital heart disease (CCHD) is a compensatory response to chronic hypoxia which should be managed with caution. CCHD patients, who have compensated erythrocytosis but do not manifest significant neurologic symptoms, may experience secondary life-threatening complications such as stroke in case of inappropriate phlebotomy. This study reports a young man with CCHD who developed frequently repeated transient neurologic deficits with various presentations after one session of phlebotomy. The symptoms resolved a few days after the hematocrit (Hct) level returned to the prephlebotomy level

Directory of Open Access Journals

Reza Pourbehi, Mohamad

http://eprints.bpums.ac.ir/6119/1/CRINM2015-924862.pdf

Unusual Neurologic Manifestations of a Patient with Cyanotic Congenital Heart Disease after Phlebotomy

Abstract

Similar works

Full text

Available Versions

Crossref

Bushehr University of Medical Sciences Repository

Bushehr University of Medical Sciences Repository

Bushehr University of Medical Sciences Repository

Directory of Open Access Journals

Bushehr University of Medical Sciences Repository

Bushehr University of Medical Sciences Repository